CreditAccess Grameen Bilan de santé

Santé financière contrôle des critères 2/6

CreditAccess Grameen possède un total de capitaux propres de ₹69.9B et une dette totale de ₹191.5B, ce qui porte son ratio d'endettement à 274.1%. Son actif total et son passif total sont ₹266.1B et de ₹196.2B.

Informations clés

274.1%

Ratio d'endettement

₹191.54b

Dette

Ratio de couverture des intérêts	n/a
Argent liquide	₹18.45b
Fonds propres	₹69.88b
Total du passif	₹196.24b
Total des actifs	₹266.13b

Mises à jour récentes de la santé financière

Pas de mise à jour

Recent updates

Is Now The Time To Put CreditAccess Grameen (NSE:CREDITACC) On Your Watchlist?

Oct 18

Potential Upside For CreditAccess Grameen Limited (NSE:CREDITACC) Not Without Risk

Sep 13

If EPS Growth Is Important To You, CreditAccess Grameen (NSE:CREDITACC) Presents An Opportunity

Jun 11

If EPS Growth Is Important To You, CreditAccess Grameen (NSE:CREDITACC) Presents An Opportunity

Aug 02

How Much Did CreditAccess Grameen's(NSE:CREDITACC) Shareholders Earn From Share Price Movements Over The Last Year?

Feb 28

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de CREDITACC ( ₹256.5B ) dépassent ses passifs à court terme ( ₹1.3B ).

Passif à long terme: Les actifs à court terme de CREDITACC ( ₹256.5B ) dépassent ses passifs à long terme ( ₹195.0B ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de CREDITACC ( 247.7% ) est considéré comme élevé.

Réduire la dette: Le ratio d'endettement de CREDITACC est passé de 220.8% à 274.1% au cours des 5 dernières années.

Couverture de la dette: Le flux de trésorerie opérationnel de CREDITACC est négatif, par conséquent la dette n'est pas bien couverte.

Couverture des intérêts: Données insuffisantes pour déterminer si les paiements d'intérêts de CREDITACC sur sa dette sont bien couverts par l'EBIT.

CreditAccess Grameen Bilan de santé

Santé financière contrôle des critères 2/6

Informations clés

Mises à jour récentes de la santé financière

Recent updates

Now 20% overvalued

Consensus EPS estimates fall by 37%

Price target decreased by 15% to ₹1,318

Second quarter 2025 earnings: EPS misses analyst expectations

Is Now The Time To Put CreditAccess Grameen (NSE:CREDITACC) On Your Watchlist?

CreditAccess Grameen Limited to Report Q2, 2025 Results on Oct 25, 2024

Potential Upside For CreditAccess Grameen Limited (NSE:CREDITACC) Not Without Risk

CreditAccess Reportedly Scouts A New Owner with $2.7 Billion Valuation

Now 22% overvalued

First quarter 2025 earnings: EPS exceeds analyst expectations

CreditAccess Grameen Limited to Report Q1, 2025 Results on Jul 19, 2024

CreditAccess Grameen Limited, Annual General Meeting, Aug 12, 2024

Full year 2024 earnings: EPS and revenues exceed analyst expectations

Investor sentiment improves as stock rises 18%

If EPS Growth Is Important To You, CreditAccess Grameen (NSE:CREDITACC) Presents An Opportunity

Full year 2024 earnings: EPS and revenues exceed analyst expectations

Investors Aren't Buying CreditAccess Grameen Limited's (NSE:CREDITACC) Earnings

New minor risk - Shareholder dilution

Is Now The Time To Put CreditAccess Grameen (NSE:CREDITACC) On Your Watchlist?

Third quarter 2024 earnings: EPS misses analyst expectations

Is Now The Time To Put CreditAccess Grameen (NSE:CREDITACC) On Your Watchlist?

Price target increased by 8.0% to ₹1,691

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

CreditAccess Grameen Limited to Report Q2, 2024 Results on Oct 20, 2023

CreditAccess Grameen Limited Announces Resignation of Narayanan M., Chief Integration Officer

If EPS Growth Is Important To You, CreditAccess Grameen (NSE:CREDITACC) Presents An Opportunity

CreditAccess Grameen Limited, Annual General Meeting, Aug 25, 2023

Creditaccess Grameen Limited Appoints Ganesh Narayanan as CEO

Price target increased by 7.3% to ₹1,511

First quarter 2024 earnings released: EPS: ₹21.93 (vs ₹8.85 in 1Q 2023)

CreditAccess Grameen Limited to Report Q1, 2024 Results on Jul 21, 2023

CreditAccess Grameen Limited to Report Q1, 2024 Results on Jul 21, 2023

Investor sentiment improves as stock rises 18%

Price target increased by 7.1% to ₹1,362

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Third quarter 2023 earnings released: EPS: ₹13.59 (vs ₹7.69 in 3Q 2022)

CreditAccess Grameen Limited to Report Q3, 2023 Results on Feb 07, 2023

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

CreditAccess Grameen Limited to Report Q2, 2023 Results on Oct 21, 2022

CreditAccess Grameen Limited Announces Cessation of Directorship of Sucharita Mukherjee as Independent Director

CreditAccess Grameen Limited Approves Re-Designation of M. J. Mahadev Prakash as Company Secretary & Chief Compliance Officer, Effective October 1, 2022

CreditAccess Grameen Limited to Report Q1, 2023 Results on Jul 29, 2022

Full year 2022 earnings: EPS and revenues exceed analyst expectations

CreditAccess Grameen Limited, Annual General Meeting, Jul 25, 2022

Investor sentiment deteriorated over the past week

Price target increased to ₹1,122

CreditAccess Grameen Limited to Report Fiscal Year 2022 Results on May 12, 2022

Price target increased to ₹1,019

Investor sentiment improved over the past week

Price target increased to ₹960

Price target increased to ₹920

Investor sentiment improved over the past week

Head of Operational Excellence recently sold ₹2.6m worth of stock

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Price target increased to ₹833

MD, CEO & Whole-Time Director recently sold ₹3.2m worth of stock

MD, CEO & Whole-Time Director recently sold ₹19m worth of stock

Second quarter 2022 earnings released: EPS ₹4.08 (vs ₹5.50 in 2Q 2021)

Insider recently sold ₹1.3m worth of stock

Insider recently sold ₹1.9m worth of stock

First quarter 2022 earnings released: EPS ₹1.45 (vs ₹5.00 in 1Q 2021)

Consensus EPS estimates fall to ₹24.55

Non-Executive Chairman Paolo Brichetti has left the company

Full year 2021 earnings released: EPS ₹8.96 (vs ₹23.20 in FY 2020)

Business Head of Group Lending recently sold ₹4.1m worth of stock

Price target decreased to ₹790

Full year 2021 earnings released: EPS ₹8.96 (vs ₹23.20 in FY 2020)

MD, CEO & Whole-Time Director recently sold ₹9.9m worth of stock

How Much Did CreditAccess Grameen's(NSE:CREDITACC) Shareholders Earn From Share Price Movements Over The Last Year?

Chief Audit Officer recently sold ₹5.3m worth of stock

New 90-day low: ₹689

Creditaccess Grameen Limited Announces Appointment of Mr. George Joseph, Independent Director as Vice Chairman and Lead Independent Director

Third quarter 2021 earnings released: ₹5.12 loss per share (vs ₹7.51 profit in 3Q 2020)

CreditAccess Grameen Limited to Report Q3, 2021 Results on Jan 29, 2021

New 90-day high: ₹815

CreditAccess Grameen Limited Announces Retirement of Mr. Diwakar B.R as Director Finance, Effective November 6, 2020